Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term extension study of lecozotan SR in mild to moderate Alzheimer's disease
2005-001476-13Phase 2Completed
- Sponsor
- Wyeth
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lecozotan in Alzheimer's disease (AD) (3 arms), sponsored by Wyeth. Primary endpoint: Safety and tolerability of long-term lecozotan SR therapy. Started Apr 2006; status: completed.
02
Drugs
lecozotan
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2005-001476-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001476-13.